MARKET

TRVI

TRVI

Trevi Therapeutics
NASDAQ
6.60
0.00
0.00%
After Hours: 6.44 -0.16 -2.42% 19:59 05/09 EDT
OPEN
7.13
PREV CLOSE
6.60
HIGH
7.17
LOW
6.37
VOLUME
1.43M
TURNOVER
--
52 WEEK HIGH
7.39
52 WEEK LOW
2.300
MARKET CAP
671.52M
P/E (TTM)
-14.0485
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on Top Healthcare Stocks: Zymeworks (ZYME), Joint (JYNT)
TipRanks · 14h ago
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Pliant Therapeutics (PLRX) and Qiagen (QGEN)
TipRanks · 17h ago
Trevi Therapeutics Reports Q1 2025 Results and Updates
TipRanks · 23h ago
Trevi Therapeutics GAAP EPS of -$0.09 beats by $0.03
Seeking Alpha · 1d ago
Trevi Therapeutics reports Q EPS (9c), consensus (12c)
TipRanks · 1d ago
TREVI THERAPEUTICS INC: EXPECTED CASH RUNWAY INTO Q4 OF 2026
Reuters · 1d ago
Earnings Scheduled For May 8, 2025
Benzinga · 1d ago
Earnings Preview For Trevi Therapeutics
Benzinga · 2d ago
More
About TRVI
More
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), chronic cough in patients with non-IPF interstitial lung disease, and refractory chronic cough. Haduvio is an oral extended-release (ER) formulation of nalbuphine. Nalbuphine is a mixed kappa-opioid receptor agonist and mu-opioid receptor antagonist. It has conducted a Phase II clinical trial and an open-label extension study of Haduvio in pruritus in patients with prurigo nodularis and a Phase IIb/III clinical trial. The Company’s Haduvio development programs include Chronic Cough in IPF Program, RCC Program, and Prurigo Nodularis Program. The Company’s subsidiary is Trevi Therapeutics Limited.
Recently
Symbol
Price
%Change

Webull offers Trevi Therapeutics Inc stock information, including NASDAQ: TRVI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRVI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TRVI stock methods without spending real money on the virtual paper trading platform.